Literature detail

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.

Jun Lan1 Jiwan Ge1 Jinfang Yu1 Sisi Shan2 Huan Zhou3 Shilong Fan1 Qi Zhang2 Xuanling Shi2 Qisheng Wang3 Linqi Zhang4 Xinquan Wang5
Affiliations 5 institutions
  1. The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life Sciences, Tsinghua University, Beijing, China.
  2. Center for Global Health and Infectious Diseases, Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China.
  3. Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, China.
  4. Center for Global Health and Infectious Diseases, Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China. [email protected].
  5. The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life Sciences, Tsinghua University, Beijing, China. [email protected].
PMID 32225176 2020 Nature eng ppublish
PubMed DOI Browse context

Article

Publication summary

A new and highly pathogenic coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) caused an outbreak in Wuhan city, Hubei province, China, starting from December 2019 that quickly spread nationwide and to other countries around the world<sup>1-3</sup>. Here, to better understand the initial step of infection at an atomic level, we determined the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2. The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also uses ACE2 as the cell receptor<sup>4</sup>. Structural analysis identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, the majority of which either are highly conserved or share similar side chain properties with those in the SARS-CoV RBD. Such similarity in structure and sequence strongly indicate convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2, although SARS-CoV-2 does not cluster within SARS and SARS-related coronaviruses<sup>1-3,5</sup>. The epitopes of two SARS-CoV antibodies that target the RBD are also analysed for binding to the SARS-CoV-2 RBD, providing insights into the future identification of cross-reactive antibodies.

Amino Acid Sequence Angiotensin-Converting Enzyme 2 Antibodies, Neutralizing Betacoronavirus Binding Sites Conserved Sequence Crystallography, X-Ray Epitopes Evolution, Molecular Humans Hydrogen Bonding Models, Molecular Peptidyl-Dipeptidase A Protein Binding Protein Domains Receptors, Virus Salts SARS-CoV-2

Structured evidence records

Evidence records

3 total
1 records
Extraction confidence 0.70
Key finding

Structural and sequence analyses of the spike receptor-binding domain showed that SARS-CoV-2 and SARS-CoV exhibit convergent evolution for improved ACE2 binding.

Virus
Location
Not specified
Supporting text

Structural analysis identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, the majority of which are highly conserved or share similar side chain properties with those in the SARS-CoV RBD. Such similarity in structure and sequence strongly indicate convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs.

Genes or proteins
spike; receptor-binding domain
Analysis methods
structural analysis; sequence alignment
1 records
Extraction confidence 0.90
Key finding

SARS-CoV-2 spike receptor-binding domain shows molecular adaptation via conserved and convergently evolved residues that enhance ACE2 receptor binding compared to related coronaviruses.

Virus
Host
Not specified
Location
Not specified
Supporting text

We determined the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2. Structural analysis identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, and similarity in structure and sequence indicates convergent evolution between SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2.

Genes or proteins
spike; RBD
Receptors
ACE2
Mechanism types
receptor_binding; host_factor_interaction; convergent_evolution
1 records
Extraction confidence 1.00
Key finding

SARS-CoV-2 spike protein binds the ACE2 receptor in a mode nearly identical to that of SARS-CoV, indicating shared receptor usage and conserved binding residues.

Virus
Location
Not specified
Supporting text

We determined the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2. The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also uses ACE2 as the cell receptor.

Method
crystal structure determination; structural analysis
Receptors
ACE2